Permanent pacemaker dependency in patients with new left bundle branch block and new first degree atrioventricular block after transcatheter aortic valve implantation.
Aged
Aged, 80 and over
Atrioventricular Block
/ complications
Bundle-Branch Block
/ complications
Cardiac Pacing, Artificial
Causality
Electrophysiological Phenomena
Female
Heart Valve Prosthesis
Humans
Male
Pacemaker, Artificial
Retrospective Studies
Transcatheter Aortic Valve Replacement
/ adverse effects
Treatment Outcome
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 12 2021
21 12 2021
Historique:
received:
03
07
2021
accepted:
22
11
2021
entrez:
22
12
2021
pubmed:
23
12
2021
medline:
27
1
2022
Statut:
epublish
Résumé
Conduction disorders with need for permanent pacemaker (PPM) implantation remain frequent complications after transcatheter aortic valve implantation (TAVI). Up to 22% of PPM after TAVI are implanted for new onset left bundle branch block (LBBB) and atrioventricular block (AVB) I. However, clinical benefit and predictors of ventricular pacing in TAVI patients receiving PPM for this indication remain unclear. We retrospectively evaluated pacemaker interrogation data of patients who received a PPM post TAVI for new LBBB and new AVB I. The primary endpoint of this study was relevant ventricular pacing (ventricular pacing rate: Vp ≥ 1%) at the first outpatient pacemaker interrogation. Secondary endpoints were predictors for relevant ventricular pacing. At the first pacemaker interrogation (median follow up at 6.23 [2.8-14.8] months), median ventricular pacing frequency was 1.0% [0.1-17.8]. Out of 61 patients, 36 (59%) had Vp rates ≥ 1%. Patients with frequent ventricular pacing showed longer QRS duration (155 ms ± 17 ms vs. 144 ms ± 18 ms, p = 0.018) at the time of PPM implantation and were less likely treated with a balloon-expandable Edwards Sapiens Valve (39% vs. 12%, p = 0.040). Our findings suggest that the majority of patients with new LBBB and new AVB I after TAVI show relevant ventricular pacing rates at follow up. Further prospective studies are necessary to identify patients at higher risk of pacemaker dependency.
Identifiants
pubmed: 34934073
doi: 10.1038/s41598-021-03667-0
pii: 10.1038/s41598-021-03667-0
pmc: PMC8692410
doi:
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
24383Informations de copyright
© 2021. The Author(s).
Références
Pacing Clin Electrophysiol. 2018 Sep;41(9):1178-1184
pubmed: 29931693
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Pacing Clin Electrophysiol. 2014 Dec;37(12):1592-601
pubmed: 25223835
Eur Heart J. 2014 May;35(18):1186-94
pubmed: 24347317
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1509-1518
pubmed: 30093055
J Am Coll Cardiol. 2019 Aug 27;74(8):1086-1106
pubmed: 31439219
JACC Cardiovasc Interv. 2018 Feb 12;11(3):301-310
pubmed: 29413244
Eur Heart J. 2020 Aug 1;41(29):2771-2781
pubmed: 31899484
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2200-2209
pubmed: 27832845
Eur Heart J. 2019 Feb 1;40(5):456-465
pubmed: 30590565
Circulation. 2014 Mar 18;129(11):1233-43
pubmed: 24370552
Arq Bras Cardiol. 2017 Dec;109(6):550-559
pubmed: 29185614
J Am Coll Cardiol. 2014 Jul 15;64(2):129-40
pubmed: 25011716
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
Wien Klin Wochenschr. 2016 Mar;128(5-6):198-203
pubmed: 26745972
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1495-1505
pubmed: 30031719
Arch Cardiovasc Dis. 2013 Apr;106(4):209-19
pubmed: 23706367
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053